| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.83B | 19.58B | 19.31B | 18.88B | 17.82B | 15.33B |
| Gross Profit | 7.01B | 6.91B | 6.88B | 7.08B | 6.66B | 6.84B |
| EBITDA | 8.93B | 8.87B | 9.06B | 9.06B | 8.86B | 7.57B |
| Net Income | 4.40B | 4.39B | 3.79B | 4.19B | 5.17B | 8.25B |
Balance Sheet | ||||||
| Total Assets | 171.39B | 177.10B | 166.62B | 152.32B | 149.99B | 154.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.37B | 14.06B | 8.67B | 5.31B | 9.88B | 21.55B |
| Total Debt | 78.64B | 84.35B | 75.53B | 67.16B | 64.86B | 66.65B |
| Total Liabilities | 94.47B | 100.78B | 91.74B | 81.45B | 79.48B | 83.50B |
| Stockholders Equity | 76.92B | 76.32B | 74.87B | 70.87B | 70.51B | 70.54B |
Cash Flow | ||||||
| Free Cash Flow | 1.34B | 3.36B | 1.26B | -3.98B | -9.77B | -5.67B |
| Operating Cash Flow | 1.69B | 7.29B | 8.22B | 8.92B | 2.74B | 7.69B |
| Investing Cash Flow | -349.78M | -8.22B | -11.27B | -12.10B | -8.65B | -5.57B |
| Financing Cash Flow | -1.23B | 6.26B | 6.41B | -1.38B | -5.76B | 6.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥129.20B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
73 Outperform | ¥4.06T | 16.16 | 9.64% | 0.97% | 0.49% | 12.19% | |
71 Outperform | ¥90.88B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥1.40T | 11.39 | 13.29% | 3.25% | 45.15% | 19.80% | |
65 Neutral | ¥742.33B | 6.28 | 10.59% | 2.94% | -19.09% | 16.31% | |
57 Neutral | ¥926.39B | 17.83 | 7.40% | 3.68% | 3.52% | -17.58% |